American Society For Radiation Oncology Applauds President Obama’s Health Priorities

The American Society for Radiation Oncology (ASTRO) applauds President Obama’s healthcare reform priorities set forth in his February 26, 2009, budget blueprint, particularly the President’s promise to double funding for cancer research and close loopholes that are weakening the Medicare program.
Remarkable breakthroughs in cancer research and medical technology continue to make radiation therapy an effective, [...]

Siemens Sets A New Standard For Breast Ultrasound

New automated breast ultrasound system automatically acquires volumes and offers intelligent clinical applications. Siemens Healthcare recently introduced the Acuson S2000 Automated Breast Volume Scanner (ABVS), the first multi-use ultrasound breast system that automatically acquires volume images of the breast. Thanks to the user-independent, standardized image acquisition, the system is ideally suited for early detection and [...]

Ascenta Therapeutics Announces Positive Preliminary Results With AT-101 In Docetaxel Refractory Prostate Cancer

Ascenta Therapeutics announced positive preliminary results from its Phase II study of AT-101 in combination with docetaxel and prednisone (D/P) in men with docetaxel refractory, castrate resistant prostate cancer (CRPC) at the American Society of Clinical Oncology (ASCO) Genitourinary Cancers Symposium in Orlando, FL. AT-101, an oral, pan-Bcl-2 inhibitor currently in double-blinded, randomized Phase II [...]

New Tool Guides Doctors To Save Cancer Patients’ Fertility

The powerful chemotherapy and radiation used to save cancer patients’ lives can also destroy their fertility.
Research in a new field called oncofertility has advanced the ability of doctors to preserve the reproductive health of women, men and children who are diagnosed with cancer. Yet, many oncologists aren’t familiar with these new strategies to help their [...]

Latest Advances In Minimally Invasive Medicine Featured March 7-12 In San Diego

The Society of Interventional Radiology (SIR) will present the latest research on treatments for individuals with kidney, prostate and bone cancer; herniated disks; peripheral arterial disease (PAD) and related complications; childbirth difficulties; and more at its 34thAnnual Scientific Meeting March 7 – 12 at the San Diego Convention Center in San Diego, Calif.
Cancer Advances
Using Focal [...]

New Test May Mean Faster Breast Cancer Treatment

Genetic analysis method can be used on all women with diagnosis, study says
A new genetic test that analyzes a set of 50 genes to identify four types of breast cancer could lead to quicker, more immediate treatment for patients, according to U.S. researchers who developed the test.
“Unlike a widely used genomic test that [...]

Researchers Identify Potential Therapeutic Target In Osteosarcoma

A receptor known to be active in bone metastases, but previously unexplored in primary bone tumors, is a potential therapeutic target in osteosarcoma, investigators from The University of Texas M. D. Anderson Cancer Center report in the March 1 issue of Cancer Research.
The researchers found that the protein – interleukin-11 receptor alpha (IL-11Ra) – is [...]

Cell Microenvironments Hold Key To Future Stem Cell Therapies

Adult stem cells and their more committed kin, progenitor cells, are prized by medical researchers for their ability to produce different types of specialized cells. The potential of using these cells to repair or replace damaged tissue holds great promise for cancer therapies and regenerative medicine. However, the question that must first be answered is [...]

March Is National Colorectal Cancer Awareness Month

The Cancer Institute of New Jersey (CINJ) is making experts available to discuss risk factors, treatment and prevention options surrounding colorectal cancer. According to the American Cancer Society, nearly 149,000 new cases of the disease were diagnosed in the United States last year with 4,600 new cases in New Jersey. Colorectal cancer is the third [...]

25 Breast Cancer Myths and Misunderstandings

1. Myth: Only women with a family history of breast cancer are at risk.
Reality: Roughly 70 percent of women diagnosed with breast cancer have no identifiable risk factors for the disease. But the family-history risks are these: If a first-degree relative (a parent, sibling, or child) has had or has breast cancer, your risk of [...]